{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:41:32Z","timestamp":1792456892901,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400155"],"award-info":[{"award-number":["82400155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772036"],"award-info":[{"award-number":["2025M772036"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH319"],"award-info":[{"award-number":["ZR2022QH319"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Universities Youth Innovation Team Development Plan","award":["2024KJJ033"],"award-info":[{"award-number":["2024KJJ033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune thrombocytopenia (ITP) is one of the most common autoimmune hemorrhagic disorders and is characterized by frequent relapses that require repeated hospitalization. Although overweight\/obesity and metabolic disorders have been linked to ITP, their association with readmission risk remains unclear. A cohort of 3,811 patients with a discharge diagnosis of ITP was identified from the National Readmission Database (NRD) for this retrospective analysis. Patients were classified into four phenotypes according to overweight\/obesity status and metabolic status: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Readmissions were assessed at 30, 60, 90, 120, 150, and 180 days. Multivariable Cox proportional hazards models were used to evaluate the association between metabolic overweight\/obesity phenotypes and readmission risk in this cohort. At 120, 150, and 180 days, patients with metabolically unhealthy phenotypes had a significantly higher risk of readmission than those with the MHNO phenotype. In contrast, the MHO phenotype was not associated with increased readmission risk. Subsequent stratified analyses showed a gradual increase in readmission risk with a higher number of concurrent metabolic risk factors. Among patients with ITP, metabolic disorders, rather than overweight\/obesity, were associated with an increased risk of readmission after multivariable adjustment. Readmission risk also increased with the number of concurrent metabolic risk factors. Notably, the association between metabolic comorbidities and ITP-related readmission showed a distinct time-dependent pattern. Because this study did not include a non-ITP control group, whether this association is specific to ITP or reflects a broader effect of metabolic comorbidities on readmission remains uncertain.<\/jats:p>","DOI":"10.1007\/s00277-026-07182-y","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:29:37Z","timestamp":1784802577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between metabolic overweight\/obesity phenotypes and readmission risk in patients with Immune Thrombocytopenia (ITP): a national retrospective study"],"prefix":"10.1007","volume":"105","author":[{"given":"Fuxin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingquan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"7182_CR1","doi-asserted-by":"crossref","unstructured":"Sheng Z et al (2025) The single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia. Blood","DOI":"10.1182\/blood.2025028960"},{"issue":"11","key":"7182_CR2","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.3390\/cimb46110709","volume":"46","author":"SS Zheng","year":"2024","unstructured":"Zheng SS, Perdomo JS (2024) Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment. Curr Issues Mol Biol 46(11):11942\u201311956","journal-title":"Curr Issues Mol Biol"},{"key":"7182_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/JBM.S259101","volume":"12","author":"F Song","year":"2021","unstructured":"Song F, Al-Samkari H (2021) Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice. J Blood Med 12:653\u2013664","journal-title":"J Blood Med"},{"issue":"6","key":"7182_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000338935","volume":"35","author":"M Bauer","year":"2012","unstructured":"Bauer M et al (2012) A retrospective observational single-centre study on the burden of immune thrombocytopenia (ITP). Onkologie 35(6):342\u2013348","journal-title":"Onkologie"},{"issue":"11","key":"7182_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2459\/JCM.0000000000001025","volume":"21","author":"CW Cheng","year":"2020","unstructured":"Cheng CW, Liu MH, Wang CH (2020) Predictors of infection-related rehospitalization in heart failure patients and its impact on long-term survival. J Cardiovasc Med (Hagerstown) 21(11):889\u2013896","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"5","key":"7182_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/ijgc-2022-003765","volume":"33","author":"D Huang","year":"2023","unstructured":"Huang D et al (2023) Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcome. Int J Gynecol Cancer 33(5):741\u2013748","journal-title":"Int J Gynecol Cancer"},{"issue":"24","key":"7182_CR7","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMp1901225","volume":"380","author":"RK Wadhera","year":"2019","unstructured":"Wadhera RK, Yeh RW (2019) Joynt Maddox, The Hospital Readmissions Reduction Program - Time for a Reboot. N Engl J Med 380(24):2289\u20132291","journal-title":"N Engl J Med"},{"issue":"3","key":"7182_CR8","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S2589-7500(19)30028-7","volume":"1","author":"E Hypp\u00f6nen","year":"2019","unstructured":"Hypp\u00f6nen E et al (2019) A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank. Lancet Digit Health 1(3):e116\u2013e126","journal-title":"Lancet Digit Health"},{"issue":"9","key":"7182_CR9","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1007\/s00277-024-05836-3","volume":"103","author":"Z Xiao","year":"2024","unstructured":"Xiao Z et al (2024) Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study. Ann Hematol 103(9):3453\u20133461","journal-title":"Ann Hematol"},{"key":"7182_CR10","doi-asserted-by":"publisher","first-page":"101577","DOI":"10.1016\/j.eclinm.2022.101577","volume":"51","author":"Z Yuan","year":"2022","unstructured":"Yuan Z et al (2022) Association between metabolic overweight\/obesity phenotypes and readmission risk in patients with lung cancer: A retrospective cohort study. EClinicalMedicine 51:101577","journal-title":"EClinicalMedicine"},{"issue":"10","key":"7182_CR11","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/diacare.28.10.2588a","volume":"28","author":"F Guerrero-Romero","year":"2005","unstructured":"Guerrero-Romero F, Rodr\u00edguez-Mor\u00e1n M (2005) Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 28(10):2588\u20132589","journal-title":"Diabetes Care"},{"issue":"19","key":"7182_CR12","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486\u20132497","journal-title":"JAMA"},{"key":"7182_CR13","doi-asserted-by":"publisher","first-page":"1026751","DOI":"10.3389\/fpubh.2022.1026751","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H et al (2022) Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China. Front Public Health 10:1026751","journal-title":"Front Public Health"},{"key":"7182_CR14","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M (2020) Metabolically healthy obesity. Endocr Rev 41(3)","DOI":"10.1210\/endrev\/bnaa004"},{"key":"7182_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/VHRM.S168946","volume":"15","author":"S Carbone","year":"2019","unstructured":"Carbone S et al (2019) Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag 15:89\u2013100","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"7182_CR16","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1172\/JCI129186","volume":"129","author":"GI Smith","year":"2019","unstructured":"Smith GI, Mittendorfer B, Klein S (2019) Metabolically healthy obesity: facts and fantasies. J Clin Invest 129(10):3978\u20133989","journal-title":"J Clin Invest"},{"issue":"3","key":"7182_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3803\/EnM.2020.301","volume":"35","author":"N Stefan","year":"2020","unstructured":"Stefan N (2020) Metabolically Healthy and Unhealthy Normal Weight and Obesity. Endocrinol Metab (Seoul) 35(3):487\u2013493","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"7182_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1210\/jc.2018-01321","volume":"104","author":"JB Echouffo-Tcheugui","year":"2019","unstructured":"Echouffo-Tcheugui JB et al (2019) Natural History of Obesity Subphenotypes: Dynamic Changes Over Two Decades and Prognosis in the Framingham Heart Study. J Clin Endocrinol Metab 104(3):738\u2013752","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"7182_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N et al (2018) Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90\u2008257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol 6(9):714\u2013724","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"7182_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","volume":"16","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Antoniades C (2019) The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol 16(2):83\u201399","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"7182_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V et al (2018) Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 17(1):122","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"7182_CR22","doi-asserted-by":"publisher","first-page":"e36936","DOI":"10.1097\/MD.0000000000036936","volume":"103","author":"MA Madkhali","year":"2024","unstructured":"Madkhali MA (2024) Recent advances in the management of immune thrombocytopenic purpura (ITP): A comprehensive review. Med (Baltim) 103(3):e36936","journal-title":"Med (Baltim)"},{"issue":"5","key":"7182_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00277-022-04786-y","volume":"101","author":"N Vianelli","year":"2022","unstructured":"Vianelli N et al (2022) Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. Ann Hematol 101(5):963\u2013978","journal-title":"Ann Hematol"},{"key":"7182_CR24","doi-asserted-by":"publisher","first-page":"107803","DOI":"10.1016\/j.phrs.2025.107803","volume":"217","author":"X Zhou","year":"2025","unstructured":"Zhou X, Shan NN (2025) The metabolism-immunity axis in Immune thrombocytopenia: from energy regulation to targeted therapy. Pharmacol Res 217:107803","journal-title":"Pharmacol Res"},{"issue":"6","key":"7182_CR25","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1111\/sji.70077","volume":"102","author":"X Zhou","year":"2025","unstructured":"Zhou X et al (2025) Untargeted Metabolomic Profiling Reveals Lipid Metabolism Dysregulation in Patients With Immune Thrombocytopenia. Scand J Immunol 102(6):e70077","journal-title":"Scand J Immunol"},{"issue":"7121","key":"7182_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860\u2013867","journal-title":"Nature"},{"issue":"10","key":"7182_CR27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nri.2017.66","volume":"17","author":"MM Mehta","year":"2017","unstructured":"Mehta MM, Weinberg SE, Chandel NS (2017) Mitochondrial control of immunity: beyond ATP. Nat Rev Immunol 17(10):608\u2013620","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"7182_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1017\/S0029665112000092","volume":"71","author":"FP de Heredia","year":"2012","unstructured":"de Heredia FP, G\u00f3mez-Mart\u00ednez S, Marcos A (2012) Obesity, inflammation and the immune system. Proc Nutr Soc 71(2):332\u2013338","journal-title":"Proc Nutr Soc"},{"key":"7182_CR29","doi-asserted-by":"crossref","unstructured":"Balistreri CR, Caruso C, Candore G (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010: 802078","DOI":"10.1155\/2010\/802078"},{"issue":"4","key":"7182_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu MS et al (2017) Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 13(4):851\u2013863","journal-title":"Arch Med Sci"},{"key":"7182_CR31","doi-asserted-by":"publisher","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M et al (2021) Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne) 12:585887","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"7182_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","volume":"88","author":"A Najaoui","year":"2012","unstructured":"Najaoui A et al (2012) Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP). Eur J Haematol 88(2):167\u2013174","journal-title":"Eur J Haematol"},{"issue":"1","key":"7182_CR33","first-page":"115","volume":"17","author":"E Hanafy","year":"2017","unstructured":"Hanafy E, Pakra MA (2017) Immune Thrombocytopenia and Obesity: Predictive Relationship. Ochsner J 17(1):115\u2013117","journal-title":"Ochsner J"},{"issue":"1","key":"7182_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12964-025-02368-9","volume":"23","author":"JH Han","year":"2025","unstructured":"Han JH (2025) Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling. Cell Commun Signal 23(1):373","journal-title":"Cell Commun Signal"},{"issue":"1","key":"7182_CR35","doi-asserted-by":"publisher","first-page":"e13403","DOI":"10.1111\/imr.13403","volume":"329","author":"PK Anand","year":"2025","unstructured":"Anand PK (2025) From fat to fire: The lipid-inflammasome connection. Immunol Rev 329(1):e13403","journal-title":"Immunol Rev"},{"issue":"1","key":"7182_CR36","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.bvth.2025.100129","volume":"3","author":"A Lucchesi","year":"2026","unstructured":"Lucchesi A et al (2026) Inflammatory cytokines, inflammasomes, and neutrophil extracellular traps in primary immune thrombocytopenia pathogenesis. Blood Vessel Thromb Hemost 3(1):100129","journal-title":"Blood Vessel Thromb Hemost"},{"issue":"4","key":"7182_CR37","doi-asserted-by":"publisher","first-page":"e24852","DOI":"10.1002\/jcla.24852","volume":"37","author":"Y Su","year":"2023","unstructured":"Su Y, Zhang T, Qiao R (2023) Pyroptosis in platelets: Thrombocytopenia and inflammation. J Clin Lab Anal 37(4):e24852","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"7182_CR38","doi-asserted-by":"publisher","first-page":"e3003620","DOI":"10.1371\/journal.pbio.3003620","volume":"24","author":"YS Lee","year":"2026","unstructured":"Lee YS (2026) Immunometabolism in obesity: Understanding the beneficial and detrimental roles of inflammation. PLoS Biol 24(1):e3003620","journal-title":"PLoS Biol"},{"issue":"10","key":"7182_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/ajh.21500","volume":"84","author":"MD Danese","year":"2009","unstructured":"Danese MD et al (2009) Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol 84(10):631\u2013635","journal-title":"Am J Hematol"},{"issue":"23","key":"7182_CR40","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3(23):3829\u20133866","journal-title":"Blood Adv"},{"issue":"22","key":"7182_CR41","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3(22):3780\u20133817","journal-title":"Blood Adv"},{"issue":"7","key":"7182_CR42","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1002\/ajh.25127","volume":"93","author":"G Moulis","year":"2018","unstructured":"Moulis G et al (2018) Cardiovascular risk factors in immune thrombocytopenia adults: Results from the CARMEN registry. Am J Hematol 93(7):E181\u2013e184","journal-title":"Am J Hematol"},{"issue":"8","key":"7182_CR43","first-page":"617","volume":"41","author":"[Chinese guideline on the","year":"2020","unstructured":"[Chinese guideline on the (2020) diagnosis and management of adult primary immune thrombocytopenia (version 2020)]. Zhonghua Xue Ye Xue Za Zhi 41(8):617\u2013623","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"7182_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40170-023-00327-x","volume":"11","author":"H Dong","year":"2023","unstructured":"Dong H et al (2023) The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin\u2019s lymphoma-an observational study. Cancer Metab 11(1):24","journal-title":"Cancer Metab"},{"key":"7182_CR45","doi-asserted-by":"publisher","first-page":"1116307","DOI":"10.3389\/fonc.2023.1116307","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Association between metabolic obesity phenotypes and multiple myeloma hospitalization burden: A national retrospective study. Front Oncol 13:1116307","journal-title":"Front Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07182-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:26:24Z","timestamp":1792455984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07182-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7182"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07182-y","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study utilized data derived from the HCUP\u2011NRD database. As a de\u2011identified administrative database, all records were anonymized and contained no personally identifiable information. Under applicable regulations, including the Health Insurance Portability and Accountability Act (HIPAA), the analysis of de\u2011identified data was exempt from Institutional Review Board (IRB) approval. The study did not involve patient recruitment, biological specimen collection, or processing of identifiable private information, and therefore did not constitute human subjects research requiring ethical oversight. Accordingly, ethical approval and informed consent were deemed not applicable for this investigation. Notwithstanding the exemption from ethical review, all study procedures were performed in strict adherence to the principles of the Declaration of Helsinki, maintaining methodological rigor and safeguarding data confidentiality and security.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"464"}}